[Leu8,des-Arg9]bradykinin [4695]
[Leu8,des-Arg9]bradykinin
| SMILES |
CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCN=C(N)N)C(=O)O |
| InChIKey |
BGAPYBBQGHUQNM-YYGRSCHNSA-N |
| Sequence |
RPPGFSPL |
| HELM |
PEPTIDE1{R.P.P.G.F.S.P.L}$$$$ |
Chemical Properties
| Hydrogen bond acceptors |
11 |
| Hydrogen bond donors |
9 |
| Rotatable bonds |
21 |
| Log P |
-2.723 |
| Molecular weight (Da) |
869.5 |
| Stereochemistry info |
unspecified |
Bioactivities
|
| Receptor |
Activity |
Source |
| Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
|
| Receptor |
Activity |
Source |
| Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
[Leu8,des-Arg9]bradykinin
Drug properties
| Molecular type |
Peptide |
| Physiological/Surrogate |
Surrogate |
| Approved drug |
No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0
Compound is not listed as a drug.